Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Amortization of Deferred Charges (2024 - 2025)

Historic Amortization of Deferred Charges for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to $468000.0.

  • Kestra Medical Technologies' Amortization of Deferred Charges fell 2547.77% to $468000.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $1.5 million, marking a year-over-year increase of 3179.49%. This contributed to the annual value of $1.4 million for FY2025, which is 2750.46% up from last year.
  • As of Q4 2025, Kestra Medical Technologies' Amortization of Deferred Charges stood at $468000.0, which was down 2547.77% from $469000.0 recorded in Q3 2025.
  • In the past 5 years, Kestra Medical Technologies' Amortization of Deferred Charges ranged from a high of $628000.0 in Q4 2024 and a low of $82000.0 during Q1 2024